Nalaganje...
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma
Lung cancer is the leading cause of cancer death worldwide with low response rates to conventional chemotherapy. New promising therapies have emerged based on programmed cell death protein 1 (PD-1) immunity checkpoint inhibitors (ICI), including anti-PD-1, such as nivolumab and pembrolizumab, or pro...
Shranjeno v:
| izdano v: | J Thorac Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353738/ https://ncbi.nlm.nih.gov/pubmed/30775032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.103 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|